GW & Wade’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $2.5M | Sell |
31,333
-1,464
| -4% | -$110K | 0.08% | 154 |
|
|
2023
Q3 | $2.33M | Buy |
32,797
+1,700
| +5% | +$127K | 0.09% | 147 |
|
|
2023
Q2 | $2.4M | Buy |
31,097
+126
| +0.4% | +$9.75K | 0.09% | 144 |
|
|
2023
Q1 | $2.33M | Sell |
30,971
-854
| -3% | -$63.5K | 0.09% | 139 |
|
|
2022
Q4 | $2.51M | Buy |
31,825
+171
| +0.5% | +$12.8K | 0.1% | 130 |
|
|
2022
Q3 | $2.22M | Sell |
31,654
-176,861
| -85% | -$13.9M | 0.11% | 127 |
|
|
2022
Q2 | $16.7M | Buy |
208,515
+2,142
| +1% | +$167K | 0.76% | 40 |
|
|
2022
Q1 | $15.6M | Buy |
206,373
+5,655
| +3% | +$448K | 0.67% | 48 |
|
|
2021
Q4 | $17.1M | Buy |
200,718
+3,165
| +2% | +$247K | 0.74% | 43 |
|
|
2021
Q3 | $14.9M | Buy |
197,553
+2,086
| +1% | +$166K | 0.71% | 47 |
|
|
2021
Q2 | $15.9M | Buy |
195,467
+1,806
| +0.9% | +$148K | 0.76% | 43 |
|
|
2021
Q1 | $15.3M | Buy |
193,661
+10,983
| +6% | +$861K | 0.81% | 39 |
|
|
2020
Q4 | $15.6M | Buy |
182,678
+5,427
| +3% | +$449K | 0.95% | 36 |
|
|
2020
Q3 | $13.7M | Sell |
177,251
-1,686
| -0.9% | -$129K | 1.04% | 31 |
|
|
2020
Q2 | $13.1M | Sell |
178,937
-2,063
| -1% | -$147K | 1.07% | 27 |
|
|
2020
Q1 | $12M | Buy |
181,000
+9,635
| +6% | +$680K | 1.13% | 26 |
|
|
2019
Q4 | $11.8M | Buy |
171,365
+5,838
| +4% | +$398K | 0.91% | 36 |
|
|
2019
Q3 | $12.2M | Buy |
165,527
+2,999
| +2% | +$218K | 1.04% | 30 |
|
|
2019
Q2 | $11.6M | Sell |
162,528
-141
| -0.1% | -$10K | 1.06% | 30 |
|
|
2019
Q1 | $11.1M | Buy |
162,669
+7,884
| +5% | +$509K | 1.05% | 30 |
|
|
2018
Q4 | $9.21M | Sell |
154,785
-3,641
| -2% | -$228K | 1% | 32 |
|
|
2018
Q3 | $10.6M | Buy |
158,426
+3,752
| +2% | +$250K | 1.13% | 33 |
|
|
2018
Q2 | $10M | Buy |
154,674
+2,608
| +2% | +$171K | 1.13% | 31 |
|
|
2018
Q1 | $10.9M | Buy |
152,066
+841
| +0.6% | +$60.5K | 1.26% | 26 |
|
|
2017
Q4 | $11.4M | Buy |
151,225
+1,058
| +0.7% | +$77.3K | 1.31% | 27 |
|
|
2017
Q3 | $10.9M | Sell |
150,167
-4,415
| -3% | -$318K | 1.33% | 28 |
|
|
2017
Q2 | $11.5M | Buy |
154,582
+508
| +0.3% | +$37.7K | 1.45% | 21 |
|
|
2017
Q1 | $11.3M | Buy |
154,074
+63,541
| +70% | +$4.45M | 1.48% | 23 |
|
|
2016
Q4 | $5.92M | Sell |
90,533
-13,117
| -13% | -$899K | 0.98% | 28 |
|
|
2016
Q3 | $7.68M | Sell |
103,650
-1,086
| -1% | -$80.3K | 1.38% | 18 |
|
|
2016
Q2 | $7.67M | Buy |
104,736
+2,299
| +2% | +$164K | 1.32% | 18 |
|
|
2016
Q1 | $7.24M | Buy |
102,437
+5,149
| +5% | +$343K | 1.41% | 17 |
|
|
2015
Q4 | $6.48M | Buy |
97,288
+5,686
| +6% | +$378K | 1.36% | 19 |
|
|
2015
Q3 | $5.81M | Sell |
91,602
-1,796
| -2% | -$117K | 1.29% | 19 |
|
|
2015
Q2 | $6.11M | Sell |
93,398
-4,668
| -5% | -$317K | 1.21% | 19 |
|
|
2015
Q1 | $6.8M | Buy |
98,066
+23,825
| +32% | +$1.65M | 1.28% | 16 |
|
|
2014
Q4 | $5.14M | Sell |
74,241
-1,087
| -1% | -$73.4K | 1.35% | 22 |
|
|
2014
Q3 | $4.91M | Sell |
75,328
-725
| -1% | -$47.8K | 1.43% | 24 |
|
|
2014
Q2 | $5.18M | Sell |
76,053
-142
| -0.2% | -$9.52K | 1.53% | 21 |
|
|
2014
Q1 | $4.94M | Sell |
76,195
-75
| -0.1% | -$4.73K | 1.6% | 19 |
|
|
2013
Q4 | $4.97M | Sell |
76,270
-2,615
| -3% | -$167K | 1.61% | 17 |
|
|
2013
Q3 | $4.68M | Sell |
78,885
-412
| -0.5% | -$24.4K | 1.62% | 15 |
|
|
2013
Q2 | $4.54M | Buy |
+79,297
| New | +$4.71M | 1.64% | 14 |
|
Other funds holding CL
GW & Wade's CL Position: Q4 2023 in Review
GW & Wade reduced its Colgate-Palmolive (CL) stake by 4.5% in Q4 2023, selling an estimated $110K and leaving 31,333 shares worth $2.5M. The position accounts for 0.08% of the portfolio, ranked #154.
GW & Wade first reported a position in CL in Q2 2013 and has held it in 43 quarters since. The position peaked at $17.1M in Q4 2021. 1,741 funds tracked by Wall St. Rank hold CL as of Q4 2023.
- GW & Wade held 31,333 shares of Colgate-Palmolive worth $2.5M as of Q4 2023.
- GW & Wade sold 1,464 Colgate-Palmolive shares in Q4 2023, an estimated $110K.
- Colgate-Palmolive made up 0.08% of GW & Wade's portfolio in Q4 2023, its #154 holding.
- GW & Wade first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 43 quarters since.
- GW & Wade's Colgate-Palmolive position peaked at $17.1M in Q4 2021.
- 1,741 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2023.
Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.